Labcorp, a global life sciences company, completed the acquisition of the Vectra testing business of Myriad, a molecular diagnostic company. Financial terms were not disclosed. “Labcorp has consistently been a major player in rheumatology and continues to focus on providing medical professionals with the data they need to best treat their RA patients. The addition of the Vectra testing capabilities to our in-house products offers tremendous potential for us to expand the test’s availability and make Labcorp a single-source diagnostics solution for RA providers. We look forward to welcoming the team to Labcorp," Brian Caveney, Labcorp Managing Director, Chief Medical Officer and President.